NRT Smoking Cessation Aids - Guatemala

Date: May 22, 2010
Pages: 22
Price:
US$ 900.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: NAC383E27B4EN
Leaflet:

Download PDF Leaflet

In February 2009, Guatemala became a smoke-free country with the new anti-tobacco law which prohibits smoking in closed places such as restaurants, bars, discotheques and museums. Individuals who break this law, can be fined up to 10 minimum daily salaries, US$65 approximately, and institutions can be fined from US$628-US$1,316 to the closing of the establishment. This drove NRT smoking cessation aids to grow by 8% in current value terms to reach sales of GTQ3 million, driven by more smokers...

Euromonitor International's NRT Smoking Cessation Aids Products in Guatemala report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Nrt Smoking Cessation Aids in Guatemala
Euromonitor International
May 2010
List of Contents and Tables
Executive Summary
Consumer Healthcare Grows at A Slower Pace
Changing Consumer Lifestyles Impact Consumer Healthcare
Generic Brands and Multinationals Dominate
Chained Outlets Take Over Distribution
Modest Growth Ahead
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Advertising
Packaging and Labelling
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Definitions
Analgesics
Cough, Cold and Allergy (hay Fever) Remedies
Digestive Remedies
Medicated Skin Care
Nrt Smoking Cessation Aids
Eye Care
Ear Care
Adult Mouth Care
Calming and Sleeping Products
Wound Treatments
OTC Obesity
Emergency Contraception
OTC Statins
OTC Triptans
Vitamins and Dietary Supplements
Slimming Products
Sports Nutrition Products
Herbal/traditional Products
Summary 1 Research Sources
Corporación Lancasco SA
Strategic Direction
Key Facts
Summary 2 Corporación Lancasco SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 3 Corporación Lancasco SA: Competitive Position 2008
Farmamédica SA
Strategic Direction
Key Facts
Summary 4 Farmamédica SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 5 Farmamédica SA: Competitive Position 2009
Laboratorios Laprin SA
Strategic Direction
Key Facts
Summary 6 Laboratorios Laprin SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 7 Laboratorios Laprin SA: Competitive Position 2009
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Indicators
Table 11 Number of Smokers by Gender 2004-2009
Category Data
Table 12 Sales of Smoking Cessation Aids by Subsector: Value 2004-2009
Table 13 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2004-2009
Table 14 NRT Gum Flavours: % Value Breakdown 2006-2009
Table 15 Smoking Cessation Aids Company Shares by Value 2005-2009
Table 16 Smoking Cessation Aids Brand Shares by Value 2006-2009
Table 17 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2009-2014
Table 18 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2009-2014
Skip to top


NRT Smoking Cessation Aids in Guatemala US$ 990.00 May, 2013 · 17 pages
NRT Smoking Cessation Aids in India US$ 990.00 Sep, 2016 · 24 pages
NRT Smoking Cessation Aids in Italy US$ 990.00 Sep, 2016 · 21 pages
NRT Smoking Cessation Aids in Lithuania US$ 990.00 Apr, 2013 · 21 pages
NRT Smoking Cessation Aids - Malaysia US$ 900.00 May, 2010 · 33 pages

Ask Your Question

NRT Smoking Cessation Aids - Guatemala
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: